Insider Transactions in Q1 2023 at Prometheus Biosciences, Inc. (RXDX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-31.19%
|
$2,900,000
$116.14 P/Share
|
|
Mar 15
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+23.78%
|
$50,000
$2.9 P/Share
|
|
Mar 08
2023
|
Sinai Intellectual Property CO Cedars > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
865,000
-17.78%
|
$98,610,000
$114.59 P/Share
|
|
Mar 06
2023
|
Keith W Marshall Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-50.48%
|
$1,220,000
$122.13 P/Share
|
|
Mar 06
2023
|
Keith W Marshall Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+33.54%
|
$30,000
$3.7 P/Share
|
|
Mar 03
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
10,620
-16.15%
|
$1,327,500
$125.13 P/Share
|
|
Mar 03
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,620
+13.9%
|
$31,860
$3.7 P/Share
|
|
Mar 01
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
700
-1.25%
|
$87,500
$125.26 P/Share
|
|
Mar 01
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
700
+1.24%
|
$2,100
$3.7 P/Share
|
|
Feb 17
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
13,680
-19.88%
|
$1,710,000
$125.1 P/Share
|
|
Feb 17
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,680
+16.58%
|
$41,040
$3.7 P/Share
|
|
Feb 16
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-31.19%
|
$2,975,000
$119.87 P/Share
|
|
Feb 16
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+23.78%
|
$75,000
$3.7 P/Share
|
|
Feb 15
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-31.19%
|
$2,975,000
$119.42 P/Share
|
|
Feb 15
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+23.78%
|
$50,000
$2.9 P/Share
|
|
Feb 15
2023
|
Keith W Marshall Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-33.76%
|
$595,000
$119.38 P/Share
|
|
Feb 15
2023
|
Keith W Marshall Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.24%
|
$15,000
$3.7 P/Share
|
|
Jan 17
2023
|
Keith W Marshall Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-33.76%
|
$595,000
$119.0 P/Share
|
|
Jan 17
2023
|
Keith W Marshall Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.24%
|
$15,000
$3.7 P/Share
|
|
Jan 17
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-31.19%
|
$2,950,000
$118.99 P/Share
|
|
Jan 17
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+23.78%
|
$50,000
$2.9 P/Share
|